More specifically, FCD type II is associated with abnormalities in regulation of the mechanistic target of rapamycin (mTOR), a central kinase involved in cell growth and proliferation (Ljungberg et al., 2006). Here, MTOR is linked to isolated focal cortical dysplasia type II.